transitioning from tirzepatide to semaglutide Switch Semaglutide: Safety Guide – PlexusDx switching from tirzepatide to semaglutide

Subscribe to the free InSight+ weekly newsletter here

How Policy Shifts Could Expand Obesity Drug Coverage A major barrier preventing widespread access to GLP-1 medications is the lack of insurance coverage, especially for weight loss

Retatrutide is the worlds most advanced triple hormone receptor agonist, simultaneously activating GLP-1, GIP and glucagon receptors to reduce appetite, improve metabolic health and raise energy expenditure

Ensure that you are physically active and taking a healthy diet that aligns with the weight-reducing effect of the medication

Here are five signs you may be a good fit, plus the qualifying criteria your provider will actually look at